TCM
DXCM icon

Triumph Capital Management’s DexCom DXCM Stock Holding History

Triumph Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539 Hold
8
– – ﹤0.01% 1724
2026
Q1 		$502 Buy
8
+6
+300% +$418 ﹤0.01% 1698
2025
Q4 		$133 Buy
+2
New +$129 ﹤0.01% 1734
2024
Q1 		– Sell
-9,004
Closed -$1.12M – 233
2023
Q4 		$1.12M Buy
+9,004
New +$920K 0.47% 48

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Triumph Capital Management's DXCM Position: Q2 2026 in Review

Triumph Capital Management held its DexCom (DXCM) position steady in Q2 2026 at 8 shares worth $539. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Triumph Capital Management first reported a position in DXCM in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.12M in Q4 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Triumph Capital Management held 8 shares of DexCom worth $539 as of Q2 2026.
  • Triumph Capital Management left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1724 holding.
  • Triumph Capital Management first reported a position in DexCom in Q4 2023 and has held it in 4 quarters since.
  • Triumph Capital Management's DexCom position peaked at $1.12M in Q4 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.